Skip to Content Facebook Feature Image

Rivermate Launches as a Unified Global Employer of Record Platform, Bringing Together Eos Global Expansion, Serviap Global, and Hightekers' EOR Operations

Business

Rivermate Launches as a Unified Global Employer of Record Platform, Bringing Together Eos Global Expansion, Serviap Global, and Hightekers' EOR Operations
Business

Business

Rivermate Launches as a Unified Global Employer of Record Platform, Bringing Together Eos Global Expansion, Serviap Global, and Hightekers' EOR Operations

2026-04-28 20:00 Last Updated At:20:15

One global brand. 38 owned legal entities. Coverage in 180+ countries, serving companies and professionals wherever work happens.

LONDON and DUBAI, UAE, April 28, 2026 /PRNewswire/ -- Hightekers, Eos Global Expansion, Serviap Global, and Rivermate today announced the unification of their Employer of Record (EOR) services under a single global brand: Rivermate.

The combined entity brings together over 15 years of operational experience — anchored by Eos Global Expansion's and Serviap Global's founding in 2010 — across Latin America, Asia, Europe, and the Middle East. Rivermate now delivers EOR services through 38 wholly owned legal entities worldwide, supported by in-country teams and an extensive network of trusted local partners, enabling coverage across 180+ countries and supporting over 3,500 workers globally.

Through this operational and brand consolidation, the four entities now operate as one global company under the Rivermate name — delivering a more consistent, controlled, and locally grounded approach to international hiring, EOR, Contractor of Record (COR), and payroll.

Existing client contracts and service delivery are unaffected. Clients will continue working with their existing contacts, with the added benefit of expanded global capabilities across the unified platform.

Commenting on the news, Roger Oudiz, Chairman of the Group, said:

"We are not just renaming companies. We are building a global infrastructure for the future of work. Bringing Eos, Serviap, and our Hightekers EOR operations under the Rivermate brand is the right move at the right time — it gives our clients a single, trusted partner wherever they hire, and gives our teams the platform they deserve to compete globally. The regional expertise that made each of these businesses great is not going anywhere. It is now part of something bigger."

One company, two brands

This consolidation is part of a broader group strategy to build the world's most comprehensive global work intermediary: a platform that serves both companies navigating international expansion and professionals seeking to work on their own terms — across Employer of Record, Contractor of Record, global payroll, and freelancer management. It establishes a two-brand structure, with each brand serving a distinct market and mission.

Rivermate becomes the group's single global brand for Employer of Record (EOR), Contractor of Record (COR), and Contractor Payment solutions. The Serviap and Eos brands will be retired, with their operations, teams, and client relationships continuing within Rivermate.

Hightekers will continue to operate as a distinct brand, serving independent professionals globally through a premium freelancer management solution. With an established market presence and a loyal customer base, Hightekers retains its own identity, teams, and commercial focus.

About Rivermate

Rivermate is a global Employer of Record (EOR) provider that enables companies to hire, manage, and pay employees internationally — combining owned infrastructure with local expertise and dedicated human support. Built on 15 years of experience across Europe, Asia, and Latin America, Rivermate operates through 38 wholly owned entities and a network of 150+ trusted partners, covering 180+ countries and supporting 3,500+ workers worldwide.

Website: https://rivermate.com/ 

Media contact: press@rivermate.com

One global brand. 38 owned legal entities. Coverage in 180+ countries, serving companies and professionals wherever work happens.

LONDON and DUBAI, UAE, April 28, 2026 /PRNewswire/ -- Hightekers, Eos Global Expansion, Serviap Global, and Rivermate today announced the unification of their Employer of Record (EOR) services under a single global brand: Rivermate.

The combined entity brings together over 15 years of operational experience — anchored by Eos Global Expansion's and Serviap Global's founding in 2010 — across Latin America, Asia, Europe, and the Middle East. Rivermate now delivers EOR services through 38 wholly owned legal entities worldwide, supported by in-country teams and an extensive network of trusted local partners, enabling coverage across 180+ countries and supporting over 3,500 workers globally.

Through this operational and brand consolidation, the four entities now operate as one global company under the Rivermate name — delivering a more consistent, controlled, and locally grounded approach to international hiring, EOR, Contractor of Record (COR), and payroll.

Existing client contracts and service delivery are unaffected. Clients will continue working with their existing contacts, with the added benefit of expanded global capabilities across the unified platform.

Commenting on the news, Roger Oudiz, Chairman of the Group, said:

"We are not just renaming companies. We are building a global infrastructure for the future of work. Bringing Eos, Serviap, and our Hightekers EOR operations under the Rivermate brand is the right move at the right time — it gives our clients a single, trusted partner wherever they hire, and gives our teams the platform they deserve to compete globally. The regional expertise that made each of these businesses great is not going anywhere. It is now part of something bigger."

One company, two brands

This consolidation is part of a broader group strategy to build the world's most comprehensive global work intermediary: a platform that serves both companies navigating international expansion and professionals seeking to work on their own terms — across Employer of Record, Contractor of Record, global payroll, and freelancer management. It establishes a two-brand structure, with each brand serving a distinct market and mission.

Rivermate becomes the group's single global brand for Employer of Record (EOR), Contractor of Record (COR), and Contractor Payment solutions. The Serviap and Eos brands will be retired, with their operations, teams, and client relationships continuing within Rivermate.

Hightekers will continue to operate as a distinct brand, serving independent professionals globally through a premium freelancer management solution. With an established market presence and a loyal customer base, Hightekers retains its own identity, teams, and commercial focus.

About Rivermate

Rivermate is a global Employer of Record (EOR) provider that enables companies to hire, manage, and pay employees internationally — combining owned infrastructure with local expertise and dedicated human support. Built on 15 years of experience across Europe, Asia, and Latin America, Rivermate operates through 38 wholly owned entities and a network of 150+ trusted partners, covering 180+ countries and supporting 3,500+ workers worldwide.

Website: https://rivermate.com/ 

Media contact: press@rivermate.com

** This press release is distributed by PR Newswire through automated distribution system, for which the client assumes full responsibility. **

Rivermate Launches as a Unified Global Employer of Record Platform, Bringing Together Eos Global Expansion, Serviap Global, and Hightekers' EOR Operations

Rivermate Launches as a Unified Global Employer of Record Platform, Bringing Together Eos Global Expansion, Serviap Global, and Hightekers' EOR Operations

  • New office in Boston-Cambridge innovation hub to expand partnerships with healthcare and life sciences leaders
  • Supported through a Korea Health Industry Development Institute global expansion program
  • Strategic move expected to accelerate commercialization, clinical collaborations, and market access in the United States
  • BOSTON, April 28, 2026 /PRNewswire/ -- HoneyNaps, an AI-powered sleep healthcare company specializing in sleep diagnostics and digital sleep medicine, announced that it has been selected for the Boston C&D Office Residency Program (Pharmaceutical & Medical Device Track) under South Korea's 2026 Bio-health Global Expansion Support Program (K-VIP: Korea Bio-Health Value-up Innovation Program).

    The initiative is administered by the Korea Health Industry Development Institute (KHIDI) under the Ministry of Health and Welfare and is part of the Korean government's broader strategy to strengthen the global competitiveness of domestic bio-health companies and support overseas market expansion.

    HoneyNaps will relocate its existing Boston office and establish operations at the Cambridge Innovation Center (CIC), located in Kendall Square, Cambridge, Massachusetts.

    Strategic Presence in the World's Leading Biotech Cluster
    Kendall Square, located in the Boston-Cambridge area, is widely recognized as one of the world's most concentrated biotech and healthcare innovation ecosystems. The district is home to leading pharmaceutical companies, biotech startups, hospitals, research institutions, and venture capital firms.

    Anchored by institutions such as Massachusetts Institute of Technology, the area offers a uniquely integrated environment where research and development, clinical validation, commercialization, and investment are closely connected.

    For HoneyNaps, the move is expected to provide direct access to potential partners across healthcare, life sciences, and digital health sectors, while creating new opportunities for proof-of-concept projects, joint research, and strategic collaborations.

    Accelerating U.S. Market Expansion
    Through its new presence in Kendall Square, HoneyNaps plans to deepen relationships with hospitals, sleep centers, pharmaceutical companies, and healthcare innovators across the U.S. East Coast.

    The company also intends to expand clinical and commercialization partnerships in sleep medicine, leveraging the region's globally connected healthcare network.

    The residency program provides participating companies with office space, networking opportunities, local business events, and market-entry support. Additional services include consulting, strategic partnership development, and access to local innovation programs.

    Executive Comment
    Sean Ha (Taekyoung Ha), President of HoneyNaps USA, stated:
    "We have been preparing for global expansion through our existing U.S. subsidiary in Boston and establishing a presence in Kendall Square marks an important next step in expanding both research collaborations and commercialization opportunities. Being part of the same ecosystem as companies such as Pfizer, Moderna, Novartis, and Eli Lilly and Company will help us accelerate partnerships in sleep disorder clinical trials and strengthen our global market position."

    About HoneyNaps
    HoneyNaps is a South Korea-based digital health company specializing in AI-driven sleep diagnostics, sleep disorder analytics, and next-generation sleep healthcare solutions. The company develops technologies that improve access, efficiency, and clinical accuracy in sleep medicine through artificial intelligence and scalable healthcare platforms.

    For further information, please contact:
    HoneyNaps USA, Inc.
    Christine Kwon / Managing Director
    Email: sleep@honeynaps.com
    Address: 14th Floor, One Broadway, Cambridge, MA 02142
    Website: www.honeynaps.com

BOSTON, April 28, 2026 /PRNewswire/ -- HoneyNaps, an AI-powered sleep healthcare company specializing in sleep diagnostics and digital sleep medicine, announced that it has been selected for the Boston C&D Office Residency Program (Pharmaceutical & Medical Device Track) under South Korea's 2026 Bio-health Global Expansion Support Program (K-VIP: Korea Bio-Health Value-up Innovation Program).

The initiative is administered by the Korea Health Industry Development Institute (KHIDI) under the Ministry of Health and Welfare and is part of the Korean government's broader strategy to strengthen the global competitiveness of domestic bio-health companies and support overseas market expansion.

HoneyNaps will relocate its existing Boston office and establish operations at the Cambridge Innovation Center (CIC), located in Kendall Square, Cambridge, Massachusetts.

Strategic Presence in the World's Leading Biotech Cluster
Kendall Square, located in the Boston-Cambridge area, is widely recognized as one of the world's most concentrated biotech and healthcare innovation ecosystems. The district is home to leading pharmaceutical companies, biotech startups, hospitals, research institutions, and venture capital firms.

Anchored by institutions such as Massachusetts Institute of Technology, the area offers a uniquely integrated environment where research and development, clinical validation, commercialization, and investment are closely connected.

For HoneyNaps, the move is expected to provide direct access to potential partners across healthcare, life sciences, and digital health sectors, while creating new opportunities for proof-of-concept projects, joint research, and strategic collaborations.

Accelerating U.S. Market Expansion
Through its new presence in Kendall Square, HoneyNaps plans to deepen relationships with hospitals, sleep centers, pharmaceutical companies, and healthcare innovators across the U.S. East Coast.

The company also intends to expand clinical and commercialization partnerships in sleep medicine, leveraging the region's globally connected healthcare network.

The residency program provides participating companies with office space, networking opportunities, local business events, and market-entry support. Additional services include consulting, strategic partnership development, and access to local innovation programs.

Executive Comment
Sean Ha (Taekyoung Ha), President of HoneyNaps USA, stated:
"We have been preparing for global expansion through our existing U.S. subsidiary in Boston and establishing a presence in Kendall Square marks an important next step in expanding both research collaborations and commercialization opportunities. Being part of the same ecosystem as companies such as Pfizer, Moderna, Novartis, and Eli Lilly and Company will help us accelerate partnerships in sleep disorder clinical trials and strengthen our global market position."

About HoneyNaps
HoneyNaps is a South Korea-based digital health company specializing in AI-driven sleep diagnostics, sleep disorder analytics, and next-generation sleep healthcare solutions. The company develops technologies that improve access, efficiency, and clinical accuracy in sleep medicine through artificial intelligence and scalable healthcare platforms.

For further information, please contact:
HoneyNaps USA, Inc.
Christine Kwon / Managing Director
Email: sleep@honeynaps.com
Address: 14th Floor, One Broadway, Cambridge, MA 02142
Website: www.honeynaps.com

** This press release is distributed by PR Newswire through automated distribution system, for which the client assumes full responsibility. **

HoneyNaps Expands into Boston's Kendall Square, Accelerating Global Partnerships in AI Sleep Healthcare

HoneyNaps Expands into Boston's Kendall Square, Accelerating Global Partnerships in AI Sleep Healthcare

Recommended Articles